The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Gene Therapy Leaves a Vicious Cycle
Open accessAbstract
The human genetic code encrypted in thousands of genes holds the secret for synthesis of proteins that drive all biological processes necessary for normal life and death. Though the genetic ciphering remains unchanged through generations, some genes get disrupted, deleted and or mutated, manifesting diseases, and or disorders. Current treatment options-chemotherapy, protein therapy, radiotherapy, and surgery available for no more than 500 diseases-neither cure nor prevent genetic errors but often cause many side effects. However, gene therapy, colloquially called "living drug," provides a one-time treatment option by rewriting or fixing errors in the natural genetic ciphering. Since gene therapy is predominantly a viral vector-based medicine, it has met with a fair bit of skepticism from both the science fraternity and patients. Now, thanks to advancements in gene editing and recombinant viral vector development, the interest of clinicians and pharmaceutical industries has been rekindled. With the advent of more than 12 different gene therapy drugs for curing cancer, blindness, immune, and neuronal disorders, this emerging experimental medicine has yet again come in the limelight. The present review article delves into the popular viral vectors used in gene therapy, advances, challenges, and perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lou, W., Ji, F., Fu, J., Han, Z., Di, W. J., & Zhang, N. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2566-4 · Cited by 5
RetractedNon-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES
Avery, O. T., MacLeod, C. M., & McCarty, M. (1944) · Journal of Experimental Medicine · doi:10.1084/jem.79.2.137 · Cited by 2,683
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
Genetic transformation of mouse embryos by microinjection of purified DNA.
Gordon, J. W., Scangos, G. A., Plotkin, D. J., Barbosa, J. A., & Ruddle, F. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7380 · Cited by 1,435
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
The human protein atlas: a spatial map of the human proteome
Thul, P. J., & Lindskog, C. (2018) · Protein Science · doi:10.1002/pro.3307 · Cited by 1,299
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
Nathwani, A. C., Reiss, U. M., Tuddenham, E. G. D., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407309 · Cited by 1,273
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Rowe, W. P., Huebner, R. J., Gilmore, L. K., Parrott, R. H., & Ward, T. G. (1953) · Experimental Biology and Medicine · doi:10.3181/00379727-84-20714 · Cited by 1,114
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Deverman, B. E., Pravdo, P. L., Simpson, B. P., Kumar, S. R., Chan, K. Y., Banerjee, A., Wu, W.-L., Yang, B., Huber, N., Pasca, S. P., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3440 · Cited by 1,061
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
Adenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
Boutin, S., Monteilhet, V., Veron, P., Leborgne, C., Benveniste, O., Montus, M. F., & Masurier, C. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.182 · Cited by 970
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 868
Here a virus, there a virus, everywhere the same virus?
Breitbart, M., & Rohwer, F. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.04.003 · Cited by 854
Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses
Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J., & Wilson, J. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/595830 · Cited by 808
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
Targeted integration of adeno-associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 784
Oncolytic virus therapy: A new era of cancer treatment at dawn
Fukuhara, H., Ino, Y., & Todo, T. (2016) · Cancer Science · doi:10.1111/cas.13027 · Cited by 774
Cd8(+) T-Cell Responses to Adeno-Associated Virus Capsid in Humans
Mingozzi, F., Maus, M. V., Hui, D. J., Sabatino, D. E., Murphy, S. L., Rasko, J. E. J., Ragni, M. V., Manno, C. S., Sommer, J., Jiang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1549 · Cited by 748
McCarty, D., Monahan, P., & Samulski, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301514 · Cited by 735
Genetic content and evolution of adenoviruses
Davison, A. J., Benkő, M., & Harrach, B. (2003) · Journal of General Virology · doi:10.1099/vir.0.19497-0 · Cited by 683
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70039-4 · Cited by 681
Wirth, T., Parker, N., & Ylä-Herttuala, S. (2013) · Gene · doi:10.1016/j.gene.2013.03.137 · Cited by 607
Oncolytic Viruses in Cancer Treatment: A Review
Lawler, S. E., Speranza, M.-C., Cho, C.-F., & Chiocca, E. A. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2064 · Cited by 592
Production and characterization of adeno-associated viral vectors
Grieger, J. C., Choi, V. W., & Samulski, R. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.207 · Cited by 581
McCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P., & Samulski, R. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302134 · Cited by 547
Hoggan, M. D., Blacklow, N. R., & Rowe, W. P. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.6.1467 · Cited by 536
An essential receptor for adeno-associated virus infection
Pillay, S., Meyer, N. L., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., et al. (2016) · Nature · doi:10.1038/nature16465 · Cited by 532
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
Abbink, P., Lemckert, A. A. C., Ewald, B. A., Lynch, D. M., Denholtz, M., Smits, S., Holterman, L., Damen, I., Vogels, R., Thorner, A. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02696-06 · Cited by 503
GENETICS OF HUMAN CELL LINES, IV. DNA-MEDIATED HERITABLE TRANSFORMATION OF A BIOCHEMICAL TRAIT
Szybalska, E. H., & Szybalski, W. (1962) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.48.12.2026 · Cited by 502
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
China Approves World's First Oncolytic Virus Therapy For Cancer Treatment
Garber, K. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj111 · Cited by 489
THPdb: Database of FDA-approved peptide and protein therapeutics
Usmani, S. S., Bedi, G., Samuel, J. S., Singh, S., Kalra, S., Kumar, P., Ahuja, A. A., Sharma, M., Gautam, A., & Raghava, G. P. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181748 · Cited by 485
Jaenisch, R. (1988) · Science · doi:10.1126/science.3287623 · Cited by 485
Brown, B. D., Venneri, M. A., Zingale, A., Sergi, L. S., & Naldini, L. (2006) · Nature Medicine · doi:10.1038/nm1398 · Cited by 484
Recent advances in (therapeutic protein) drug development
Lagassé, H. A. D., Alexaki, A., Simhadri, V. L., Katagiri, N. H., Jankowski, W., Sauna, Z. E., & Kimchi-Sarfaty, C. (2017) · F1000Research · doi:10.12688/f1000research.9970.1 · Cited by 481 · cited 2×
“In fact, more than 5,000 critical steps are involved in developing a single therapeutic protein (8).”
BackgroundGene therapy and DNA delivery systems
Ibraheem, D., Elaissari, A., & Fessi, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.041 · Cited by 454
Molecular basis of the inflammatory response to adenovirus vectors
Liu, Q., & Muruve, D. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302036 · Cited by 429
THE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANS
DAAR, A. S., FUGGLE, S. V., FABRE, J. W., TING, A., & MORRIS, P. J. (1984) · Transplantation · doi:10.1097/00007890-198409000-00018 · Cited by 406
Worgall, S., Sondhi, D., Hackett, N. R., Kosofsky, B., Kekatpure, M. V., Neyzi, N., Dyke, J. P., Ballon, D., Heier, L., Greenwald, B. M., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.022 · Cited by 402
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Bowles, D. E., McPhee, S. W., Li, C., Gray, S. J., Samulski, J. J., Camp, A. S., Li, J., Wang, B., Monahan, P. E., Rabinowitz, J. E., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.237 · Cited by 400
A viral assembly factor promotes AAV2 capsid formation in the nucleolus
Sonntag, F., Schmidt, K., & Kleinschmidt, J. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001673107 · Cited by 392
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
Eberling, J. L., Jagust, W. J., Christine, C. W., Starr, P., Larson, P., Bankiewicz, K. S., & Aminoff, M. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312381.29287.ff · Cited by 370
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
Mingozzi, F., Anguela, X. M., Pavani, G., Chen, Y., Davidson, R. J., Hui, D. J., Yazicioglu, M., Elkouby, L., Hinderer, C. J., Faella, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005795 · Cited by 355
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
Kalyuzhniy, O., Di Paolo, N. C., Silvestry, M., Hofherr, S. E., Barry, M. A., Stewart, P. L., & Shayakhmetov, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711757105 · Cited by 349
Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301377 · Cited by 349
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Crystal, R. G. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.2527 · Cited by 341
Grieger, J. C., Soltys, S. M., & Samulski, R. J. (2016) · Molecular Therapy · doi:10.1038/mt.2015.187 · Cited by 325
The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic
Zhang, W.-W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M. J., Chandler, L. A., Lin, H., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.218 · Cited by 318
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
Zinn, E., Pacouret, S., Khaychuk, V., Turunen, H. T., Carvalho, L. S., Andres-Mateos, E., Shah, S., Shelke, R., Maurer, A. C., Plovie, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.019 · Cited by 310
Barouch, D. H., Kik, S. V., Weverling, G. J., Dilan, R., King, S. L., Maxfield, L. F., Clark, S., Ng’ang’a, D., Brandariz, K. L., Abbink, P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.025 · Cited by 305
Gutless adenovirus: last-generation adenovirus for gene therapy
Alba, R., Bosch, A., & Chillon, M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302612 · Cited by 303
Virus-mediated gene delivery for human gene therapy
Giacca, M., & Zacchigna, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.008 · Cited by 302
Atkinson, R. L., Dhurandhar, N. V., Allison, D. B., Bowen, R. L., Israel, B. A., Albu, J. B., & Augustus, A. S. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802830 · Cited by 302
Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency
Wilson, J. M. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.12.016 · Cited by 299
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
Hocquemiller, M., Giersch, L., Audrain, M., Parker, S., & Cartier, N. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.087 · Cited by 291
Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., & Kovesdi, I. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6831-6838.1996 · Cited by 288
Chimpanzee Adenovirus Vector Ebola Vaccine
Ledgerwood, J. E., DeZure, A. D., Stanley, D. A., Coates, E. E., Novik, L., Enama, M. E., Berkowitz, N. M., Hu, Z., Joshi, G., Ploquin, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1410863 · Cited by 285
Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what's important?
Fausther-Bovendo, H., & Kobinger, G. P. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29594 · Cited by 276
Kaufmann, K. B., Büning, H., Galy, A., Schambach, A., & Grez, M. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202287 · Cited by 276
Bai, M., Harfe, B., & Freimuth, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5198-5205.1993 · Cited by 274
Smith, R. H., Levy, J. R., & Kotin, R. M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.128 · Cited by 261
China approves first gene therapy
Pearson, S., Jia, H., & Kandachi, K. (2004) · Nature Biotechnology · doi:10.1038/nbt0104-3 · Cited by 255
CpG-depleted adeno-associated virus vectors evade immune detection
Faust, S. M., Bell, P., Cutler, B. J., Ashley, S. N., Zhu, Y., Rabinowitz, J. E., & Wilson, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68205 · Cited by 254
Krisky, D., Wolfe, D., Goins, W., Marconi, P., Ramakrishnan, R., Mata, M., Rouse, R., Fink, D., & Glorioso, J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300766 · Cited by 251
Amalfitano, A., Hauser, M. A., Hu, H., Serra, D., Begy, C. R., & Chamberlain, J. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.926-933.1998 · Cited by 248
Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1505499 · Cited by 248
Review article: the human intestinal virome in health and disease
Carding, S. R., Davis, N., & Hoyles, L. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14280 · Cited by 247
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
De Ravin, S. S., Wu, X., Moir, S., Kardava, L., Anaya-O’Brien, S., Kwatemaa, N., Littel, P., Theobald, N., Choi, U., Su, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8856 · Cited by 244
Immune responses to AAV in a phase I study for Canavan disease
McPhee, S. W. J., Janson, C. G., Li, C., Samulski, R. J., Camp, A. S., Francis, J., Shera, D., Lioutermann, L., Feely, M., Freese, A., et al. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.885 · Cited by 241
Zhong, L., Li, B., Jayandharan, G., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Herzog, R. W., Weigel-Van Aken, K. A., Hobbs, J. A., Zolotukhin, S., et al. (2008) · Virology · doi:10.1016/j.virol.2008.08.027 · Cited by 232
Gene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.025 · Cited by 230
The population genetics of mutations: good, bad and indifferent
Loewe, L., & Hill, W. G. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0317 · Cited by 226
Buchlis, G., Podsakoff, G. M., Radu, A., Hawk, S. M., Flake, A. W., Mingozzi, F., & High, K. A. (2012) · Blood · doi:10.1182/blood-2011-09-382317 · Cited by 221
Tapia, M. D., Sow, S. O., Lyke, K. E., Haidara, F. C., Diallo, F., Doumbia, M., Traore, A., Coulibaly, F., Kodio, M., Onwuchekwa, U., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00362-x · Cited by 215
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Vandenberghe, L. H., Wang, L., Somanathan, S., Zhi, Y., Figueredo, J., Calcedo, R., Sanmiguel, J., Desai, R. A., Chen, C. S., Johnston, J., et al. (2006) · Nature Medicine · doi:10.1038/nm1445 · Cited by 208
Adeno-Associated Virus Vectorology, Manufacturing, and Clinical Applications
Grieger, J. C., & Samulski, R. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-386509-0.00012-0 · Cited by 199
Dependence of Adenovirus Infectivity on Length of the Fiber Shaft Domain
Shayakhmetov, D. M., & Lieber, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10274-10286.2000 · Cited by 197
Visual Acuity after Retinal Gene Therapy for Choroideremia
Edwards, T. L., Jolly, J. K., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Black, G. C., Webster, A. R., Lotery, A. J., Holder, G. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1509501 · Cited by 195
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease
Hoban, M. D., Orkin, S. H., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2015-09-618587 · Cited by 194
Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites
Crawford, G. E., Holt, I. E., Mullikin, J. C., Tai, D., National Institutes of Health Intramural Sequencing Center‡, Green, E. D., Wolfsberg, T. G., & Collins, F. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307540100 · Cited by 185
Gammaretroviral Vectors: Biology, Technology and Application
Maetzig, T., Galla, M., Baum, C., & Schambach, A. (2011) · Viruses · doi:10.3390/v3060677 · Cited by 183
Bispecific antibody based therapeutics: Strengths and challenges
Thakur, A., Huang, M., & Lum, L. G. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.02.004 · Cited by 183
No Love Lost Between Viruses and Interferons
Fensterl, V., Chattopadhyay, S., & Sen, G. C. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055249 · Cited by 180
Self-citationTargeting MicroRNAs in Cancer Gene Therapy
Ji, W., Sun, B., & Su, C. (2017) · Genes · doi:10.3390/genes8010021 · Cited by 174
Schambach, A., Bohne, J., Baum, C., Hermann, F. G., Egerer, L., von Laer, D., & Giroglou, T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302698 · Cited by 170
Carter, B. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.011 · Cited by 163
Human gene therapy: a brief overview of the genetic revolution.
Misra, S. (2013) · PubMed · Cited by 159
Chemical modifications of nucleic acid drugs and their delivery systems for gene‐based therapy
Chen, C., Yang, Z., & Tang, X. (2018) · Medicinal Research Reviews · doi:10.1002/med.21479 · Cited by 158
dsRNA-Activation of TLR3 and RLR Signaling: Gene Induction-Dependent and Independent Effects
Chattopadhyay, S., & Sen, G. C. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0034 · Cited by 156
Self-citationXu, X., Tan, X., Tampe, B., Wilhelmi, T., Hulshoff, M. S., Saito, S., Moser, T., Kalluri, R., Hasenfuss, G. P., Zeisberg, E. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05766-5 · Cited by 155
A New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor Cells
Tuve, S., Wang, H., Ware, C. B., Liu, Y., Gaggar, A., Bernt, K. M., Shayakhmetov, D. M., Li, Z., Strauss, R., Stone, D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01370-06 · Cited by 154
Gene therapies development: slow progress and promising prospect
Hanna, E., Rémuzat, C., Auquier, P., & Toumi, M. (2017) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2017.1265293 · Cited by 151
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Prakash, V., Moore, M., & Yáñez‐Muñoz, R. J. (2016) · Molecular Therapy · doi:10.1038/mt.2016.5 · Cited by 150
A pH-Responsive Detachable PEG Shielding Strategy for Gene Delivery System in Cancer Therapy
Guan, X., Guo, Z., Wang, T., Lin, L., Chen, J., Tian, H., & Chen, X. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00080 · Cited by 144
Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
Pesonen, S. A., Kangasniemi, L., & Hemminki, A. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100219n · Cited by 141
Symbiosis: Viruses as Intimate Partners
Roossinck, M. J., & Bazán, E. R. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042323 · Cited by 141
Ferreira, V., Twisk, J., Kwikkers, K., Aronica, E., Brisson, D., Methot, J., Petry, H., & Gaudet, D. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.169 · Cited by 137
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
Ruella, M., & Kenderian, S. S. (2017) · BioDrugs · doi:10.1007/s40259-017-0247-0 · Cited by 136
Adeno-Associated Virus Biology
Weitzman, M. D., & Linden, R. M. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-370-7_1 · Cited by 132 · cited 1×
“Although every serotype has the ability to infect cells, transport to nucleus, uncoat, and insert its genome into the host’s chromosome or leave in the episomal form, not all 13 AAV serotypes isolated to date use the same receptor repertoire on host cell surface for infection (145, 146).”
BackgroundMove Over, Bacteria! Viruses Make Their Mark as Mutualistic Microbial Symbionts
Roossinck, M. J. (2015) · Journal of Virology · doi:10.1128/jvi.02974-14 · Cited by 131
Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells
Vassena, R., Heindryckx, B., Peco, R., Pennings, G., Raya, Á., Sermon, K., & Veiga, A. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw005 · Cited by 129
Molecular Biology, Nucleic Acids, and the Future of Medicine
Tatum, E. L. (1966) · Perspectives in biology and medicine · doi:10.1353/pbm.1966.0027 · Cited by 127
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
Choudhury, S., Fitzpatrick, Z., Harris, A. F., Maitland, S. A., Ferreira, J. S., Zhang, Y., Ma, S., Sharma, R. B., Gray‐Edwards, H. L., Johnson, J. A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.84 · Cited by 125
Gene Therapy: Some History, Applications, Problems, and Prospects
Cotrim, A. P., & Baum, B. J. (2008) · Toxicologic Pathology · doi:10.1177/0192623307309925 · Cited by 115
Nemerow, G. R., Stewart, P. L., & Reddy, V. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.12.008 · Cited by 111
Adenoviruses as gene/vaccine delivery vectors: Promises and pitfalls
Appaiahgari, M. B., & Vrati, S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.993374 · Cited by 110
Mays, L. E., Vandenberghe, L. H., Xiao, R., Bell, P. L., Nam, H.-J., Agbandje‐McKenna, M., & Wilson, J. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803965 · Cited by 109
Oncolytic Viruses: Therapeutics With an Identity Crisis
Breitbach, C. J., Lichty, B. D., & Bell, J. C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.046 · Cited by 109
Machiels, J., Salazar, R., Rottey, S., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0510-7 · Cited by 107
Spliced adenovirus-associated virus RNA.
LAUGHLIN, C. A., Westphal, H., & Carter, B. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5567 · Cited by 101
Lin, C., Li, H., Hao, M., Xiong, D., Luo, Y., Huang, C., Yuan, Q., Zhang, J., & Xia, N. (2016) · Scientific Reports · doi:10.1038/srep34531 · Cited by 98
Tyrosine phosphorylation in Toll-like receptor signaling
Chattopadhyay, S., & Sen, G. C. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.06.002 · Cited by 97
Self-citationErtl, H. C. J., & High, K. A. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.172 · Cited by 94
Recent advances in oncolytic adenovirus therapies for cancer
Shaw, A. R., & Suzuki, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.06.009 · Cited by 93
Trinh, H. V., Lesage, G., Chennamparampil, V., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06181-11 · Cited by 90
Origin of the retroviruses: when, where, and how?
Hayward, A. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.06.006 · Cited by 90
Transgenic Technology in Farm Animals – Progress and Perspectives
Wolf, E., Schernthaner, W., Zakhartchenko, V., Prelle, K., Stojković, M., & Brem, G. (2000) · Experimental Physiology · doi:10.1017/s0958067000021102 · Cited by 89
Lin, S.-W., Hensley, S. E., Tatsis, N., Lasaro, M. O., & Ertl, H. C. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33138 · Cited by 88
Capone, S., D’Alise, A. M., Ammendola, V., Colloca, S., Cortese, R., Nicosia, A., & Folgori, A. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.15 · Cited by 87
Optimization of the Generation and Propagation of Gutless Adenoviral Vectors
Sakhuja, K., Reddy, P. S., Ganesh, S., Cantaniag, F., Pattison, S. T., Limbach, P., Kayda, D. B., Kadan, M. J., Kaleko, M., & Connelly, S. (2003) · Human Gene Therapy · doi:10.1089/10430340360535797 · Cited by 86
Mück-Häusl, M., Zhang, W., Müther, N., Rauschhuber, C., Franck, H. W. G., Merricks, E. P., Nichols, T. C., Kay, M. A., & Ehrhardt, A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.169 · Cited by 85
Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer
Kassiotis, G., & Stoye, J. P. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0277 · Cited by 83
Tu, S. P., Cui, J. T., Liston, P., Jiang, X. H., Xu, R., Lin, M. C. M., Zhu, Y. B., Zou, B., Ng, S. S., Jiang, S. H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.058 · Cited by 82
Endogenous Retroviruses: With Us and against Us
Meyer, T. J., Rosenkrantz, J. L., Carbone, L., & Chavez, S. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00023 · Cited by 81
Vandenberghe, L. H., Breous, E., Nam, H.-J., Gao, G., Xiao, R., Sandhu, A., Johnston, J., Debyser, Z., Agbandje‐McKenna, M., & Wilson, J. M. (2009) · Gene Therapy · doi:10.1038/gt.2009.101 · Cited by 80
Omenn, G. S., Lane, L., Lundberg, E. K., Beavis, R. C., Overall, C. M., & Deutsch, E. W. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00511 · Cited by 79
Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
Vetrini, F., & Ng, P. (2010) · Viruses · doi:10.3390/v2091886 · Cited by 77
Deev, R. V., Bozo, I. Y., MZHAVANADZE, N. D., et al. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415574336 · Cited by 77
Jay, F. T., LAUGHLIN, C. A., & Carter, B. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.2927 · Cited by 76
Viral and Synthetic RNA Vector Technologies and Applications
Schott, J. W., Morgan, M., Galla, M., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.143 · Cited by 76
RIG-I-like receptor-induced IRF3 mediated pathway of apoptosis (RIPA): a new antiviral pathway
Chattopadhyay, S., & Sen, G. C. (2016) · Protein & Cell · doi:10.1007/s13238-016-0334-x · Cited by 76
Self-citationLentiviral vectors can be used for full-length dystrophin gene therapy
Counsell, J. R., Asgarian, Z., Meng, J., Ferrer, V., Vink, C. A., Howe, S. J., Waddington, S. N., Thrasher, A. J., Muntoni, F., Morgan, J. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00152-5 · Cited by 75
Gene Therapy for the Treatment of Primary Immune Deficiencies
Kuo, C. Y., & Kohn, D. B. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0615-8 · Cited by 72
Nonviral Gene Therapy for Cancer: A Review
Hidai, C., & Kitano, H. (2018) · Diseases · doi:10.3390/diseases6030057 · Cited by 72
Gene therapy strategies in the treatment of hypertrophic cardiomyopathy
Prondzynski, M., Mearini, G., & Carrier, L. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2173-5 · Cited by 70
Subramanian, G., Kuzmanovic, T., Zhang, Y., Peter, C., Veleeparambil, M., Chakravarti, R., Sen, G. C., & Chattopadhyay, S. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006877 · Cited by 69
Self-citationA human trial of HSV-mediated gene transfer for the treatment of chronic pain
Wolfe, D. P., Mata, M. M., & Fink, D. J. (2009) · Gene Therapy · doi:10.1038/gt.2009.17 · Cited by 68
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
Knopp, Y., Geis, F. K., Heckl, D., Horn, S., Neumann, T., Kuehle, J., Meyer, J., Fehse, B., Baum, C., Morgan, M. A., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.006 · Cited by 67
Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA
Buzdin, A. A., Prassolov, V., & Garazha, A. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00035 · Cited by 66
Engineering HSV-1 Vectors for Gene Therapy
Goins, W. F., Huang, S., Cohen, J. B., & Glorioso, J. C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0428-0_5 · Cited by 65
Stepanenko, A. A., & Chekhonin, V. P. (2018) · Cancers · doi:10.3390/cancers10120492 · Cited by 65
Murphy, S. L., Li, H., Zhou, S., Schlachterman, A., & High, K. A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300334 · Cited by 63
Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System
Artusi, S., Miyagawa, Y., Goins, W. F., Cohen, J. B., & Glorioso, J. C. (2018) · Diseases · doi:10.3390/diseases6030074 · Cited by 63
Saydaminova, K., Ye, X., Wang, H., Richter, M., Ho, M., Chen, H., Xu, N., Kim, J., Papapetrou, E. P., Holmes, M. C., et al. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.57 · Cited by 61
Adenoviral vectors—How to use them in cancer gene therapy?
Majhen, D., & Ambriović‐Ristov, A. (2006) · Virus Research · doi:10.1016/j.virusres.2006.02.001 · Cited by 59
Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
Tazawa, H., Kuroda, S., Hasei, J., Kagawa, S., & Fujiwara, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071479 · Cited by 59
Manunta, M. D. I., Tagalakis, A. D., Attwood, M., Aldossary, A. M., Barnes, J. L., Munye, M. M., Weng, A., McAnulty, R. J., & Hart, S. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00662-2 · Cited by 58
Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China
Wang, X., Xing, M., Zhang, C., Yang, Y. H., Chi, Y., Tang, X., Zhang, H., Xiong, S., Yu, L., & Zhou, D. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.30 · Cited by 58
Deev, R. V., Леонидович, П. И., Bozo, I. Y., & Isaev, A. A. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0210-3 · Cited by 58
Herpes simplex virus as a transneuronal tracer
Norgren, R. B., & Lehman, M. N. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00008-6 · Cited by 56
Wen, S., Schneider, D. B., Driscoll, R. M., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1452 · Cited by 56
Gene Transfer Properties and Structural Modeling of Human Stem Cell-derived AAV
Smith, L. J., Ul-Hasan, T., Carvaines, S. K., Van Vliet, K., Yang, E., Wong, K. K., Agbandje-McKenna, M., & Chatterjee, S. (2014) · Molecular Therapy · doi:10.1038/mt.2014.107 · Cited by 51
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1
Castello, R., Borzone, R., D’Aria, S., Annunziata, P., Piccolo, P., & Brunetti‐Pierri, N. (2015) · Gene Therapy · doi:10.1038/gt.2015.107 · Cited by 51
Site-specific gene delivery in vivo through engineered Sendai viral envelopes
Ramani, K., Hassan, Q., Betapudi, V., Hasnain, S. E., & Sarkar, D. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11886 · Cited by 50
Self-citationLarge‐scale adenovirus and poxvirus‐vectored vaccine manufacturing to enable clinical trials
Kallel, H., & Kamen, A. (2015) · Biotechnology Journal · doi:10.1002/biot.201400390 · Cited by 50
Adeno‐Associated Virus RNA Transcription in vivo
Marcus, C. J., LAUGHLIN, C. A., & Carter, B. J. (1981) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb06443.x · Cited by 50
Li, J., Kao, K., Li, L., Yang, T., Wu, C., Horng, Y.-M., Jia, W. W.-G., & Yang, C. (2013) · Virology Journal · doi:10.1186/1743-422x-10-241 · Cited by 50
The Biotech Death of Jesse Gelsinger
Stolberg, S. G. (1999) · DigitalGeorgetown (Georgetown University Library) · Cited by 50
Deev, R. V., Леонидович, П. И., Bozo, I. Y., MZHAVANADZE, N. D., Suchkov, I. A., Chervyakov, Y. V., Staroverov, I. N., Kalinin, R. E., & Isaev, A. A. (2018) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944718786926 · Cited by 49
Yoon, A. R., Hong, J., Kim, S. W., & Yun, C. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1158707 · Cited by 46
New insights into stability of recombinant adenovirus vector genomes in mammalian cells
Rauschhuber, C., Noske, N., & Ehrhardt, A. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.01.006 · Cited by 44
Nishimoto, T., Yoshida, K., Miura, Y., Kobayashi, A., Hara, H., Ohnami, S., Kurisu, K., Yoshida, T., & Aoki, K. (2009) · Gene Therapy · doi:10.1038/gt.2009.1 · Cited by 43
Viswanathan, P., Venkaiah, B., Kumar, M. S., Rasheedi, S., Vrati, S., Bashyam, M. D., & Hasnain, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309351200 · Cited by 43
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
Sengillo, J. D., Justus, S., Cabral, T., & Tsang, S. H. (2017) · Genes · doi:10.3390/genes8020053 · Cited by 41
Genetic therapies for sickle cell disease
Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 40
Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob
Miura, Y., Yoshida, K., Nishimoto, T., Hatanaka, K., Ohnami, S., Asaka, M., Douglas, J. T., Curiel, D. T., Yoshida, T., & Aoki, K. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303007 · Cited by 38
Recombinant adeno‐associated virus‐mediated TRAIL gene therapy suppresses liver metastatic tumors
Ma, H., Liu, Y., Liu, S., Kung, H., Sun, X., Zheng, D., & Xu, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20982 · Cited by 38
Design and Production of Retro- and Lentiviral Vectors for Gene Expression in Hematopoietic Cells
Schambach, A., Swaney, W. P., & van der Loo, J. C. M. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-409-4_14 · Cited by 38
The FDA is prohibited from going germline
Cohen, I. G., & Adashi, E. Y. (2016) · Science · doi:10.1126/science.aag2960 · Cited by 38
Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2
Strobel, B., Duechs, M. J., Schmid, R., Stierstorfer, B., Bucher, H., Quast, K., Stiller, D., Hildebrandt, T., Mennerich, D., Gantner, F., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0338ma · Cited by 37
Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., Isla, A., & Solinís, M. Á. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.002 · Cited by 37
Nanotherapy for Duchenne muscular dystrophy
Nance, M. E., Hakim, C. H., Yang, N. N., & Duan, D. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1472 · Cited by 37
Mahendra, G., Kumar, S., Isayeva, T., Mahasreshti, P. J., Curiel, D. T., Stockardt, C. R., Grizzle, W. E., Alapati, V., Singh, R., Siegal, G. P., et al. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700754 · Cited by 35
Shimizu, K., Sakurai, F., Tomita, K., Nagamoto, Y., Nakamura, S.-I., Katayama, K., Tachibana, M., Kawabata, K., & Mizuguchi, H. (2014) · Molecular Therapy: Methods & Clinical Development · doi:10.1038/mtm.2014.35 · Cited by 35
Adamson-Small, L. A., Potter, M., Byrne, B. J., & Clément, N. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.151 · Cited by 35
Lowenstein, P. R., & Castro, M. G. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.07.006 · Cited by 35
Irons, E. E., Flatt, J. W., Doronin, K., Fox, T. L., Acchione, M., Stewart, P. L., & Shayakhmetov, D. M. (2013) · Journal of Virology · doi:10.1128/jvi.01070-13 · Cited by 34
Human Germline Interventions–Think First
Hildt, E. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00081 · Cited by 33
DNA delivery to ‘ex vivo’ human liver segments
Herrero, M. J., Sabater, L., Güenechea, G., Sendra, L., Montilla, A. I., Abargues, R., Navarro, V., & Aliño, S. F. (2011) · Gene Therapy · doi:10.1038/gt.2011.144 · Cited by 32
Rexin-G®, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report
Kim, S., Federman, N. C., Gordon, E. M., Hall, F. L., & Chawla, S. P. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1231 · Cited by 32
Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models
Brunetti-Pierri, N., & Ng, P. (2017) · Virus Genes · doi:10.1007/s11262-017-1471-x · Cited by 32
Yamamoto, Y., Nagasato, M., Rin, Y., Henmi, M., Ino, Y., Yachida, S., Ohki, R., Hiraoka, N., Tagawa, M., & Aoki, K. (2017) · Cancer Medicine · doi:10.1002/cam4.1185 · Cited by 32
Goss, J. R., Cascio, M., Goins, W. F., Huang, S., Krisky, D. M., Clarke, R., Johnson, J. W., Yokoyama, H., Yoshimura, N., Gold, M. S., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.246 · Cited by 30
Ho, D., Wykoff-Clary, S., Gross, C., Schneider, D. W., Jin, F., Kretschmer, P. J., & Hermiston, T. W. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.68 · Cited by 29
Miura, Y., Yamasaki, S., Davydova, J., Brown, E., Aoki, K., Vickers, S. M., & Yamamoto, M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.205 · Cited by 27
Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens
Uchida, H., Hamada, H., Nakano, K., Kwon, H., Tahara, H., Cohen, J. B., & Glorioso, J. C. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009617666170206105855 · Cited by 27
Venkaiah, B., Viswanathan, P., Habib, S., & Hasnain, S. E. (2004) · Biochemistry · doi:10.1021/bi049953q · Cited by 26
Cited by
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
Uddin, F., Rudin, C. M., & Sen, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01387 · Cited by 581
Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects
Zu, H., & Gao, D. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00608-7 · Cited by 475
Localized Interleukin-12 for Cancer Immunotherapy
Nguyen, K. G., Vrabel, M. R., Mantooth, S. M., Hopkins, J. J., Wagner, E. S., Gabaldon, T. A., & Zaharoff, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575597 · Cited by 431
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Santa Chalarca, C. F., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 365
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
Metadata
- Authors
- Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-04-24
- Volume
- 9
- Pages
- 297-297
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2941417604
- Cited by
- 347
- References
- 220
- FWCI
- 28.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.